Pinkerton Steven D, Bogart Laura M, Howerton Devery, Snyder Susan, Becker Kirsten, Asch Steven M
Department of Psychiatry and Behavioral Medicine, Center for AIDS Intervention Research, Medical College of Wisconsin, Milwaukee, WI, USA.
AIDS Care. 2009 Sep;21(9):1157-62. doi: 10.1080/09540120902729940.
The US Centers for Disease Control and Prevention recommends the expanded use of rapid HIV antibody tests in community settings to increase the proportion of persons who are aware of their HIV status. The cost of providing rapid testing services in these settings is not known. We conducted a cost survey of non-profit community clinics and community-based organizations (CBOs). The final study sample for the cost analyses included 28 community clinics and seven CBOs that offered rapid HIV testing, all of which used OraSure's OraQuick oral fluid assay. Overall, the mean per-client rapid testing cost was 36.68 dollars for HIV-negative clients (2006 dollars, provider perspective) and 44.22 dollars for preliminary-positive clients. Personnel costs accounted for 55.6% of overall testing costs for negative clients and 63.2% for preliminary-positive clients. This study contributes unique empirical data about the costs of OralQuick rapid testing that can be used by clinic and CBO directors to assess the economic impact of implementing rapid testing at their sites. The findings also could be used to inform discussions regarding national and local HIV testing policies.
美国疾病控制与预防中心建议在社区环境中扩大使用快速艾滋病毒抗体检测，以提高知晓自身艾滋病毒感染状况的人群比例。在这些环境中提供快速检测服务的成本尚不清楚。我们对非营利性社区诊所和社区组织（CBO）进行了成本调查。成本分析的最终研究样本包括28家提供快速艾滋病毒检测的社区诊所和7家CBO，所有这些机构都使用了奥然德公司的奥然快测口腔液检测法。总体而言，从提供者角度来看，艾滋病毒检测结果为阴性的客户，每次快速检测的平均成本为36.68美元（2006年美元），初步检测结果为阳性的客户为44.22美元。人员成本在阴性客户的总体检测成本中占55.6%，在初步检测结果为阳性的客户中占63.2%。这项研究提供了有关奥然快测快速检测成本的独特实证数据，诊所和CBO负责人可利用这些数据评估在其机构开展快速检测的经济影响。这些研究结果还可用于为有关国家和地方艾滋病毒检测政策的讨论提供参考。
